BioSpace News Archive

BioMidwest

New ACS Report: Decrease in Breast Cancer Mortality Rate Continues; Wide Gap for Black Women Remains Stagnant

While breast cancer death rates dropped by 43% from 1989 to 2020, Black women continue to be 40% more likely to die from the disease despite lower incidence.

October 4, 2022
·
4 min read
Drug Development

Paradigm Achieves Primary Endpoint in PARA_OA_008 Synovial Fluid Biomarker Phase 2 Clinical Trial

Paradigm Biopharmaceuticals Ltd is pleased to announce that the primary endpoint has been met and additionally significant improvement in Western Ontario and McMaster Universities Osteoarthritis Index pain and function scores were demonstrated for injectable iPPS in the PARA_OA_008 phase 2 clinical trial.

October 4, 2022
·
24 min read
Forensic Genomics Market Size, Growth, Trends | Report 2022-2030

The forensic genomics market is anticipated to witness significant growth as the majority of companies aim to use customer databases in combination with cutting-edge sequencing technologies.

October 4, 2022
·
2 min read
Business

Centerline Biomedical announces Gulam Khan as Chief Executive Officer

Centerline Biomedical, Inc. has appointed Gulam Khan , Chief Executive Officer.

October 4, 2022
·
1 min read
Oligon to Participate in the 9th Annual Fall Private Company Showcase hosted by Solebury Trout, BMO and Goodwin

Oligon™ Inc. announced today that Dr. Spyro Mousses, CEO and Co-Founder, Andrew Matricaria, CFO, and James Silver, COO, will participate in the 9th Annual Solebury Trout Fall Private Company Showcase co-hosted with BMO and Goodwin on October 13, 2022 in New York, NY.

October 4, 2022
·
1 min read
Biotech Beach

Trethera Announces Multiple Sclerosis Treatment Poster Presentation at the American Neurological Association Annual Meeting

Trethera Corporation announces an upcoming poster presentation at the 147th Annual Meeting of the American Neurological Association (ANA).

October 4, 2022
·
4 min read
Deals

Valneva Announces Closing of Upsized €102.9 Million Global Offering

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (the “Company”), a specialty vaccine company, announced today the closing of its previously announced global offering to specified categories of investors of an aggregate 21,000,000 new ordinary shares.

October 4, 2022
·
6 min read
Business

Envista Schedules Third Quarter 2022 Earnings Call

Envista Holdings Corporation (NYSE: NVST) (“Envista”) will report financial results for its third quarter 2022 on Thursday, November 3, 2022.

October 4, 2022
·
2 min read
Deals

Amylyx Pharmaceuticals Announces Launch of Public Offering

Amylyx Pharmaceuticals, Inc. (“Amylyx”) today announced the launch of an underwritten public offering of 6,000,000 shares of common stock pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (“SEC”).

October 4, 2022
·
3 min read
BioMidwest

Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - October 04, 2022

Veru Inc. announced the granting of inducement awards to seven new employees.

October 4, 2022
·
11 min read